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Abstract
Background: Hemorrhage increases inducible nitric oxide synthase (iNOS) and depletes ATP levels in various
tissues. Previous studies have shown that geldanamycin, an inducer of heat shock protein 70kDa (HSP-70) and
inhibitor of iNOS, limits both processes. Reduction in NO production limits lipid peroxidation, apoptosome
formation, and caspase-3 activation, thereby increasing cellular survival and reducing the sequelae of hemorrhage.
The poor solubility of geldanamycin in aqueous solutions, however, limits its effectiveness as a drug. 17-DMAG is a
water-soluble analog of geldanamycin that might have greater therapeutic utility. This study investigated the
effectiveness of 17-DMAG at reducing hemorrhagic injury in mouse small intestine.
Results: In mice, the hemorrhage-induced iNOS increase correlated with increases in Kruppel-like factor 6 (KLF6)
and NF-kB and a decrease in KLF4. As a result, increases in NO production and lipid peroxidation occurred.
Moreover, hemorrhage also resulted in decreased Bcl-2 and increased TNF-a, IL-6, and IL-10 concentrations, p53
protein, caspase-3 activation, and cellular ATP depletion. A shortening and widening of villi in the small intestine
was also observed. Treatment with 17-DMAG significantly reduced the hemorrhage-induced increases in iNOS
protein, jejunal alteration, and TNF-a and IL-10 concentrations, but 17-DMAG did not affect the hemorrhage-
induced increases in p53 and IL-6 concentration. 17-DMAG treatment by itself upregulated HSP-70, Bcl-2, and p53.
Conclusion: Since 17-DMAG is water soluble, bioactive, and not toxic, 17-DMAG may prove useful as a
prophylactic drug for hemorrhage.
Background
Hemorrhagic shock has been shown to cause systemic
inflammation response syndrome (SIRS), multiple organ
dysfunction syndrome (MODS), and multiple organ fail-
ure (MOF) [1]. Tissue hypoxia resulting from hemor-
rhage causes acute increases in intracellular free
calcium, 5-lipoxygenase, lipid peroxidation, cyclooxygen-
ase (COX), constitutive nitric oxide synthase, leuko-
triene B4, prostaglandin E2, interleukins, tumor necrosis
factor-a (TNF- a), caspases, Kruppel-like factor 6
(KLF6), inducible nitric oxide synthase (iNOS) [2].
There are also delayed increases in heat shock protein
70 kDa (HSP-70) and hypoxia-inducible factor-1a
(HIF1a) [3]. Hemorrhage upregulates iNOS as a result
of increases in c-jun, KLF6, and NF-kB and a decrease
in KLF4 [4,5]. Increased iNOS elevates NO production,
protein nitration, lipid peroxidation, apoptosome forma-
tion, and caspase activation; thereby leading to caspase-
dependent apoptosis [4,5].
iNOS gene silencing [5,6] or treatment with iNOS
inhibitors such as androstenediol [7], L-NAME, or L-
NIL-6 [5] reduces hemorrhage-induced injuries. In our
laboratory we have shown that geldanamycin, a natural
product from the bacterium Streptomyces hygroscopicus
that binds with high affinity to the ATP binding pocket
of HSP-90, protects mice [4] and rats [8] from hemor-
rhage-associated organ damage. A single subcutaneous
injection of geldanamycin (1 μg/g in 10% DMSO-saline
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vation, NO production, lipid peroxidation, caspase-3
activation, and apoptosis [3,4].
Geldanamycin has several drawbacks as a drug, how-
ever. Its potential toxicity, metabolic instability, poor
solubility in aqueous solutions, and the requirement that
it be administered by injection instead of orally limit its
effectiveness. 17-DMAG [17-(dimethylaminoethyla-
mino)-17-demethoxygeldanamycin; Figure 1A], a water-
soluble, bioactive analogue of geldanamycin [9,10],
would appear to have greater utility. Oral effectiveness
would make it especially useful in mass-casualty situa-
tions. An advantage that 17-DMAG has over a number
of other iNOS inhibitors is that it induces potentially
cytoprotective HSP-70 protein levels [11]. It is known
that increased levels of HSP-70 can protect cells from
tissue injury caused by a variety of stressful stimuli,
i n c l u d i n gt r a u m aa n dd i s e a s e[ 1 2 ] ,b yi n h i b i t i n gi N O S
and thereby preventing apoptosis and autophagy.
In this investigation, we explored the potential of 17-
DMAG to reduce hemorrhage injury. We used a small
intestine model for this study because it is an organ
especially sensitive to hemorrhage injury, responding
within 1 hr [3,4]. It is known that hemorrhage increases
iNOS-mediated caspase-3 cellular activity in various tis-
sues [3,4,6,13] and that caspase-3 plays a key role in
activating many downstream caspases involved in apop-
tosis [14,15]. We are the first to report that 17-DMAG
limits hemorrhage-induced injury in small intestine
in vivo by elevating Bcl-2 protein and inhibiting the
iNOS pathway, TNF-a increases, and caspase-3
activation.
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Figure 1 17-DMAG treatment increases HSP-70. (A) 17-DMAG structure. (B) Mice were treated with various doses of 17-DMAG 16 hr prior to
sham hemorrhage. After sham hemorrhage mice were allowed to respond for 6 hr before sample collection. Representative gel shown. (C)
Dose-response curve for various doses of 17-DMAG and HSP-70 (n = 5 per group). Estimated median effective dose is 10 ± 1 μg/g, calculated by
Prism program 3.0. (D) Mice were treated with vehicle or 17-DMAG at 10 mg/kg 16 hr prior to hemorrhage. After hemorrhaged mice and sham
mice were allowed to respond for 6 hr before sample collection. (n = 5 per group). Representative gel shown. (E) Densitometric quantitation of
HSP70 protein bands in panel C. *P < 0.05 vs. VEH and 17-D; **P < 0.05 vs. VEH, VEH+HE, and 17-D+HE. VEH: vehicle; HE: hemorrhage; 17-D: 17-
DMAG
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17-DMAG treatment increases inducible HSP-70
Because geldanamycin treatment induces HSP-70 [4,8],
we sought to determine if 17-DMAG would also do so.
Mice were orally administered with either vehicle or
various doses of 17-DMAG 16 hr prior to euthanization
and tissue collection. Western blot analysis showed 17-
DMAG increased HSP-70 in a dose-dependent manner,
with a medium effective dose of 10 ± 1 μg/g (Figure 1B-
C). Hemorrhage alone significantly inhibited HSP-70
(Figure 1D, lane 2 vs. lane 1 and Figure 1E). Treatment
with 17-DMAG followed by hemorrhage resulted in
lower HSP-70 levels than after treatment with 17-
DMAG alone, and the levels observed were not signifi-
cantly different from levels observed after hemorrhage
alone (Figure 1D, lane 4 vs. lane 3 and Figure 1E).
17-DMAG treatment inhibits hemorrhage-induced
increases in iNOS and KLF6 and decrease in KLF4
Consistent with previous reports [3-5,7], Figure 2 shows
that hemorrhage increased iNOS and KLF6 and
decreased KLF4 (lane 2 vs. lane 1). 17-DMAG treatment
prior to hemorrhage reversed these changes (lane 4 vs.
lane 2). 17-DMAG treatment alone did not change the
basal levels of iNOS and KLF6 but increased the KLF4
baseline (lane 3 vs. lane 1).
17-DMAG treatment inhibits hemorrhage-induced NF-B
The hemorrhage-induced increase in iNOS could be a
result of increases in NF-B since the promoter region of
t h ei N O Sg e n ec o n t a i n s1 0N F - B binding motifs [3].
We, therefore, evaluated levels of the NF-B p65 and p50
transcription factors after hemorrhage. Figure 3 shows
that hemorrhage increased NF-B p65 and p50 (lane 2
vs. lane 1). 17-DMAG treatment prior to hemorrhage
inhibited the increases (lane 4 vs. lane 2). 17-DMAG
treatment alone did not change the NF-Bp 6 5b a s a l
levels but increased the p50 baseline (lane 3 vs. lane 1).
17-DMAG treatment inhibits hemorrhage-induced
increases in NO and lipid peroxidation and decrease in
cellular ATP depletion
In agreement with previous reports [4,7], hemorrhage
increased NO production and lipid peroxidation as indi-
cated by malondialdehyde (MDA) production and cellu-
lar ATP depletion (Figure 4A-C). 17-DMAG treatment
prior to hemorrhage inhibited these increases. 17-DMAG
treatment alone did not alter NO and MDA basal levels
but increased the cellular ATP baseline (Figure 4A-C).
17-DMAG treatment inhibits hemorrhage-induced
increases in TNF-a and IL-10
Lad et al. [16] showed that hemorrhage increases TNF-
a, IL-8, and other cytokines. Using ELISA, we found
that hemorrhage increased TNF-a (Figure 4D), IL-10
production (Figure 4E), and IL-6 (data not shown). 17-
DMAG treatment prior to hemorrhage significantly
inhibited the increases in TNF-a (Figure 4D) and IL-10
production (Figure 4E), but not IL-6 (data not shown).
17-DMAG treatment alone did not alter their basal
levels (Figure 4D-E).
17-DMAG treatment inhibits hemorrhage-induced
caspase-3 activation
Hemorrhage activated caspase-3 enzymatic activity (Fig-
ure 5A) and increased levels of the active form of cas-
pase-3 protein (Figure 5B, lane 2 vs. lane 1). 17-DMAG
treatment prior to hemorrhage fully inhibited caspase-3
enzymatic activity and its protein production (Figure
5A-C). 17-DMAG treatment alone did not change the
basal levels.
17-DMAG treatment increases p53 and Bcl-2
It is known that p53 is pro-apoptotic, whereas Bcl-2 is
anti-apoptotic [3,17]. To determine if caspase-3 activa-
tion was mediated by the p53 pathway, p53 and Bcl-2
were measured by Western blotting. Figure 6 shows that
hemorrhage increased p53 and decreased Bcl-2 (Figure
6A, lane 2 vs. lane 1). When 17-DMAG was adminis-
tered prior to hemorrhage, jejunum displayed increased
levels of both p53 and Bcl-2 (lane 4 vs. lanes 2 and 1).
17-DMAG treatment alone also increased both p53 and
Bcl-2 (lane 3 vs. lane 1).
17-DMAG treatment inhibits hemorrhage-induced injury
in jejunum
Hemorrhage injured the jejunal structure. Villus appear-
ance changed (Figure 7B vs. 7A); hemorrhage reduced
villus height (Figure 7E) and increased villus width
(Figure 7F) but did not alter crypt depth (Figure 7G).
Mucosal damage, assessed using a six-tier scale [3], indi-
cated level 2.0 ± 0.3 damage for hemorrhage jejunum
compared to level 0.3 ± 0.2 for sham jejunum (Figure 7H).
17-DMAG treatment prior to hemorrhage prevented the
hemorrhage-induced damage (Figure 7D vs. 7A); villus
heights (Figure 7E) and widths (Figure 7F) in treated ani-
mals were not significantly different from those of jejunum
in sham-treated mice. 17-DMAG treatment alone did not
alter jejunum morphology (Figure 7C and 7E-H).
Discussion
Our data indicate that hemorrhage-induced injuries to
small intestine were reduced by pretreatment with orally
administered 17-DMAG. The protection we observed
correlated with a 17-DMAG-induced reduction in iNOS
and caspase-3 activity and an increase in Bcl-2 protein.
Hemorrhage can occur after a wide variety of injuries,
ranging from wound trauma to stroke, aneurysm, birth
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Page 3 of 10labor, or blast impact. Hemorrhage lowers the levels of
oxygen and nutrition available to tissues and results in
an accumulation of carbon dioxide and metabolic waste,
leading to activation of signal transduction pathways
and tissue damage [2]. In our experiments, hemorrhage
activated the iNOS pathway (Figures 2 and 3), generated
oxidative and nitrosative stress (Figure 4), and reduced
cellular ATP (Figure 4). Subsequently, caspase-3 was
activated (Figure 5) and cell death occurred (Figure 7).
These observations are consistent with those previously
described [4-7,17]. The hemorrhage-induced increase in
iNOS protein was due to increases in transcription fac-
tors NF-B and KLF6 and a decrease in KLF4 (Figures
2,3). It is known that NF-Ba n dK L F 6s t i m u l a t ei N O S
gene expression whereas KLF4 inhibits it [3].
17-DMAG treatment inhibited activation of the iNOS
pathway and caspase-3-mediated cell death mainly by
inhibiting NF-B and KLF6 and increasing KLF4. The
interpretation that iNOS inhibition leads to reduced
hemorrhage damage is reinforced by the results of stu-
dies employing iNOS gene knockout [17] and treatment
with iNOS-specific inhibitors [6,18]. How 17-DMAG
exerts its action on these iNOS transcription factors is
not completely clear and further study is required.
An increase in HSP-70 has been shown to inhibit the
iNOS increase triggered by hemorrhage [4,8]. However,
it does not appear that the ability of 17-DMAG to inhi-
bit hemorrhage damage in jejunum is due to its ability
to increase HSP-70. 17-DMAG treatment at the EC50
concentration for inducing HSP-70 markedly elevated
HSP-70 levels, but the combination of 17-DMAG treat-
ment and hemorrhage resulted in a lower level of HSP-
70 that was no different than that seen after hemorrhage
alone.
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Figure 2 17-DMAG treatment inhibits hemorrhage-induced increases in iNOS and KLF6 and decrease in KLF4. Mice were treated with 10
mg/kg 17-DMAG 16 hr prior to hemorrhage. After hemorrhage mice were allowed to respond for 6 hr before sample collection (n = 4-5 per
group). (A) Representative gel shown. (B) Densitometric quantitation of iNOS protein bands in panel A. *P < 0.05 vs. VEH, 17-D, and 17-D+HE. (C)
Densitometric quantitation of KLF4 protein bands in panel A. *P < 0.05 vs. VEH, 17-D, and 17-D+HE; **P < 0.05 vs. VEH, VEH+HE, and 17-D+HE;
***P < 0.05 vs. VEH, VEH+HE, and 17-D. (D) Densitometric quantitation of KLF6 protein bands in panel A. *P < 0.05 vs. VEH, 17-D, and 17-D+HE;
**P < 0.05 vs. VEH, VEH+HE, and 17-D. VEH: vehicle; HE: hemorrhage; 17-D: 17-DMAG
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orally, the possibility that 17-DMAG was absorbed by
small intestine, and locally protected it from hemorrhage
injury cannot be excluded. It is known that hemorrhage
induces a p38-MAPK increase [19] and a Bcl-2 decrease
(Figure 6) [19]. 17-DMAG may exert an effect on these
proteins as well. More studies are needed in this area.
Hemorrhage increased ATP depletion in agreement with
our previous report [20]. 17-DMAG treatment prevented
the depletion, probably due to its ability to upregulate
production of pyruvate dehydrogenase protein [20].
Hemorrhage increased TNF-a and IL-10 (Figure 4D-
E) and IL-6. Increased TNF-a has been observed in
other experimental models such as those for ionizing
radiation [21-25] and ischemia [26]. Inhibition of TNF-
a levels by drug treatment or antibody neutralization
results in an improvement in bone marrow regeneration
after radiation exposure [25]. Yen et al. [27] reported
that TNF-a is the key to the development of hemor-
rhage injury; Pfeifer et al. [28] showed that hemorrhage
in fact triggers increased TNF-a.I ti sl i k e l yi no u r
experiments that apoptosis was also caused by the
extrinsic pathway involving TNF-a receptors, which
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Figure 3 17-DMAG treatment inhibits hemorrhage-induced
increases in NF-B. Mice were treated with 10 mg/kg 17-DMAG 16
hr prior to hemorrhage. After hemorrhage mice were allowed to
respond for 6 hr before sample collection (n = 4-5 per group). (A)
Representative gel shown. (B) Densitometric quantitation of NF-B
p65 protein bands in panel A. *P < 0.05 vs. VEH, 17-D, and 17-D
+HE; **P < 0.05 vs. VEH, VEH+HE, and 17-D. (C) Densitometric
quantitation of NF-B p50 protein bands in panel A. *P < 0.05 vs.
VEH and 17-D+HE. VEH: vehicle; HE: hemorrhage; 17-D: 17-DMAG.
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Figure 4 17-DMAG treatment inhibits hemorrhage-induced increases in NO, lipid peroxidation, ATP depletion, and cytokines.M i c e
were treated with 10 mg/kg 17-DMAG 16 hr prior to hemorrhage. After hemorrhage mice were allowed to respond for 6 hr before sample
collection (n = 4-5 per group). Panels indicate levels measured as described in Methods: NO (A), MDA (B), cellular ATP (C), TNF-a (D), and IL-10
(E). For panels A, B, and E: *P < 0.05 vs. VEH, 17-D, and 17-D+HE. For panel C: *P < 0.05 vs. VEH, 17-D, and 17-D+HE; **P < 0.05 vs. VEH, VEH+HE,
17-D+HE; ***P < 0.05 vs. VEH, VEH+HE, and 17-D. VEH: vehicle; HE: hemorrhage; 17-D: 17-DMAG
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The fact that 17-DMAG inhibited the hemorrhage-
induced increase in TNF-a is desirable, but the fact it
also inhibited the beneficial IL-10 is undesirable in
terms of 17-DMAG’s use as a drug. The hemorrhage-
induced increase in IL-10 we observed could be a self-
defense response to injury, but its level is in the range
of pg/ml, a level too low to combat the damage. We
have shown that treatment with ng/ml levels of IL-10
are required to improve survival from a lethal dose of g-
irradiation [29].
Bcl-2 is anti-apoptotic and p53 is pro-apoptotic [30].
Hemorrhage reduced Bcl-2 and increased p53 in our
experiments, which probably partly contributed to the
damage observed. However, 17-DMAG treatment
increased not only Bcl-2 but surprisingly also p53 (Fig-
ure 6). The anti-apoptotic activity of Bcl-2 stimulated by
17-DMAG is apparently greater than the pro-apoptotic
activity of p53.
To summarize, 17-DMAG is water-soluble, distributes
to all tissues in the body, and is non-toxic in mice
[9,10]. Compared to other iNOS inhibitors, 17-DMAG
is potentially superior because of its ability to increase
HSP-70 and Bcl-2 proteins and decrease HSP-90 activity
and TNF-a concentration as well as ATP depletion. Its
water solubility and non-toxicity and the fact that 17-
DMAG is effective when administered orally make it a
promising candidate drug for ameliorating hemorrhage
injury.
Conclusion
Hemorrhage reduced the basal levels of HSP-70 and
Bcl-2, increased iNOS protein and its transcription fac-
tors, elevated NO production, lipid peroxidation, ATP
depletion, TNF-a, IL-6, IL-10 concentrations, caspase-3
activation, p53, and jejunum damage. Oral treatment
with 17-DMAG increased Bcl-2 and inactivated the cas-
pase pathway by inhibiting the iNOS pathway and the
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Figure 5 17-DMAG treatment inhibits hemorrhage-induced caspase-3 activation. Mice were treated with 10 mg/kg 17-DMAG 16 hr prior
to hemorrhage. After hemorrhage mice were allowed to respond for 6 hr before sample collection (n = 4-5 per group). (A) Representative gel
shown. (B) Densitometric quantitation of active caspase-3 protein bands in panel A. *P < 0.05 vs. VEH, 17-D, and 17-D+HE. (C) Corresponding
caspase-3 enzymatic activity. *P < 0.05 vs. VEH, 17-D, and 17-D+HE. VEH: vehicle; HE: hemorrhage; 17-D: 17-DMAG
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Page 6 of 10TNF-a increase so as to diminish jejunum injury despite
the fact it did not reduce p53. These results suggest that
17-DMAG may have significant value in preventing tis-
sue damage associated with hemorrhage.
Methods
Hemorrhage
Animal protocols were reviewed and approved by Insti-
tutional Animal Care and Use Committee at US Army
Institute of Surgical Research. Experiments were con-
ducted using the mouse model described by Song et al.
[31]. Male Swiss Webster mice weighing 25-35 g were
anesthetized with 5% isoflurane/oxygen (EZ Systems,
Palmer, PA) and 40% of their calculated blood volume
[32] removed by cardiac puncture over a period of 1
minute using a 26 gauge needle and 1.0 ml syringe
essentially as previously described [33]. Sham animals
were anesthetized and the needle inserted into the heart
but no blood was withdrawn. This procedure took no
more than 3 min to perform. Mean arterial blood pres-
sure fell from 80 to 40 mmHg within 2 h after treat-
m e n t[ 3 1 ] .M i c ew e r et h e na l l o w e dt or e s p o n dt ot h e
treatments for an additional 6 hr before they were
euthanized. A small section of jejunum was then col-
lected for histopathology assessment, immunoblotting
analysis, and biochemical assays. Small intestine was
chosen for investigation in this study because it is a sen-
sitive organ acutely damaged by hemorrhage [3,4].
17-DMAG treatment
17-DMAG [17-(dimethylaminoethylamino)-17-demethox-
ygeldanamycin] (CAS Registry No.: 707545) was obtained
from InvivoGen (San Diego, CA) and dissolved in 0.2 ml
5% dextrose saline for use. 17-DMAG is an analog of
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Figure 6 17-DMAG treatment increases p53 and Bcl-2. Mice were treated with 10 mg/kg 17-DMAG 16 hr prior to hemorrhage. After
hemorrhage mice were allowed to respond for 6 hr before sample collection (n = 4-5 per group). (A) Representative gel shown. (B)
Densitometric quantitation of p53 protein bands in panel A. *P < 0.05 vs. VEH and 17-D+HE; **P < 0.05 vs. VEH, VEH+HE, and 17-D. (C)
Densitometric quantitation of Bcl-2 protein bands in panel A. *P < 0.05 vs. VEH, 17-D, and 17-D+HE; **P < 0.05 vs. VEH and VEH+HE. VEH:
vehicle; HE: hemorrhage; 17-D: 17-DMAG
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Page 7 of 10geldanamycin, a natural product produced by Strepto-
myces hygroscopicus that binds with high affinity to the
ATP binding pocket of HSP-90 [9,10]. 17-DMAG is water
soluble, less metabolizable than geldanamycin, and distri-
butes to all tissues (http://clinicaltrials.gov/ct/show/
NCT00248521). 17-DMAG (or dextrose-saline vehicle)
was administered at various doses to mice orally using
feeding needles 16 h prior to hemorrhage.
Histopathologic assessment
Jejunal tissue specimens were rinsed in cold saline solu-
tion and immediately fixed in 10% buffered formalin
phosphate. The tissue was then embedded in paraffin,
sectioned transversely, and stained with H&E. The
mucosal crypt depth and width and villus height were
measured. Overall jejunal mucosal damage for each spe-
cimen was graded using a six-tiered scale [3].
Western blots
Jejunal tissue was minced in 100 μl Hanks’ balanced salt
solution (HBSS), sonicated, and centrifuged at 12,500 x
g for 10 min. The supernatant was then collected. The
total protein in the jejunal lysate was determined with
Bio-Rad reagent (Bio-Rad Laboratories, Richmond, CA,
USA). To investigate synthesis of HSP-70, iNOS, iNOS
transcription factors, actin, Bcl-2, and caspase-3, aliquots
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Figure 7 17-DMAG treatment inhibits hemorrhage-induced injury in jejunum. Mice were treated with 10 mg/kg 17-DMAG 16 hr prior to
hemorrhage. After hemorrhage mice were allowed to respond for 6 hr before sample collection. (n = 4-5 per group). (A-D) Representative
histology slides from jejunum of mice treated with VEH, VEH+HEMO, 17-DMAG, or 17-DMAG+HEMO. (E) Villus height measurements after
treatments. *P < 0.05 vs. VEH, 17-D, and 17-D+HE; **P < 0.05 vs. VEH, VEH+HE, and 17-D. (F) Villus width measurements after treatments. *P <
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Page 8 of 10containing 20 μg of protein in tris buffer (pH = 6.8)
containing 1% sodium dodecyl sulfate (SDS) and 1% 2-
mercaptoethanol were resolved on SDS-polyacrylamide
slab gels (Novex precast 4-20% gel; Invitrogen, Carlsbad,
CA, USA). After electrophoresis, proteins were blotted
onto a PDVF membrane (type NC, 0.45 μm; Invitrogen)
using a Novex blotting apparatus and the manufacturer’s
protocol. After blocking the membrane by incubation in
tris-buffered saline-0.5% tween20 (TBST) containing 3%
nonfat dried milk for 90 min at room temperature, the
blot was incubated for 60 min at room temperature
with monoclonal antibodies directed against actin,
KLF4, KLF6, NF-kB p65, NF-kB p50, HSP70, Bcl-2
(Santa Cruz Biotechnology, Santa Cruz, CA, USA),
iNOS (BD Signal Transduction, Sparks, MD, USA), and
caspase-3 (Epitomics, Burlingame, CA, USA) at a con-
centration of 1 μg/ml in TBST - 3% dry milk. The blot
was then washed 3 times (10 min each) with TBST
b e f o r ei n c u b a t i n gt h eb l o tf o r6 0m i na tr o o mt e m p e r a -
ture with a 1000X dilution of species-specific IgG perox-
idase conjugate (Santa Cruz Biotechnology) in TBST.
The blot was washed 6 times (5 min each) in TBST
before detection of peroxidase activity using the
Enhanced Chemiluminescence Plus (Amersham Life
Science Inc., Arlington Heights, IL, USA). Actin levels
were not altered by hemorrhage; we therefore used actin
as a control for protein loading. Protein bands of inter-
est were quantified densitometrically and normalized to
actin [4].
Nitric oxide measurements
NO production was measured under acidic conditions
as nitrite, using a commercial kit (Biomedical Research
Service, School of Medicine and Biomedical Sciences,
S t a t eU n i v e r s i t yo fN e wY o r ka tB u f f a l o ,N Y ,U S A ,
http://www.bmrservice.com).
Lipid peroxidation measurements
Malondialdehyde (MDA), a lipid peroxidation end pro-
duct, was measured colorimetrically using a commercial
lipid peroxidation assay kit (CalBiochem, San Diego,
CA, USA).
Cellular ATP measurements
Cellular ATP levels were determined using the ATP
Bioluminescence Assay Kit HS II (Roche, Mannheim,
Germany). Luminescence was measured with TD-20/20
luminometer (Turner Designs, Sunnyvale, CA, USA).
Data were normalized to total protein and the cellular
ATP level was expressed as fmol/μg protein.
Cytokine measurements
IL-6, IL-10, and TNF-a in jejunal lysates were measured
using an ELISA kit (Biocompare, South San Francisco,
CA, USA) according to the manufacturer’sp r o t o c o l .
The data are presented as pg/ml.
Caspase-3 enzymatic activity measurements
Caspase-3 activity was determined using the CASPASE-
3 Cellular Activity Assay Kit PLUS (Biomol, Plymouth
Meeting, PA, USA). In brief, 10 μl of each sample lysate
was added to wells of a 96-well plate already containing
the substrate Ac-DEVD-pNitroaniliane (Ac-DEVD-
pNA). Caspase in the lysates cleaved the substrate to
pNA as indicated by an increase in absorbance at 405
nm, which was used to determine reaction rate. Absor-
bance was measured using a SpectraMax 250 spectro-
photometric plate reader and SOFTmax Pro 3.1.1
software (Molecular Devices, San Diego, CA, USA).
Data were normalized to total protein, and caspase-3
activity was expressed as pmol pNA/min/μg protein.
Solutions
Hanks’ balanced salt solution contained in mM: 145
NaCl, 4.5 KCl, 1.3 MgCl2, 1.6 CaCl2, and 10 HEPES
(pH 7.40 at 24°C).
Statistical analysis
All data are expressed as mean ± S.E.M. One-way
ANOVA, Studentized-range test, and Bonferroni
inequality were used for comparison of groups with 5%
as a significant level.
Abbreviations
17-DMAG - 17-(dimethylaminoethylamino)-17-
demethoxygeldanamycin; iNOS - inducible nitric oxide
synthase; SIRS - systemic inflammation response syn-
drome; MODS - multiple organ dysfunction syndrome;
MOF - multiple organs failure; TNF-a -t u m o rn e c r o s i s
factor-a; KLF - Kruppel-like factor; NO - nitric oxide;
MDA - malondialdehyde; IL - interleukin; HIF1a -
hypoxia-inducible factor-1a; NF-B - nuclear factor- B;
HSP-70 - heat shock protein 70 kDa; HSP-90 - heat
shock protein 90 kDa; VEH: vehicle; HE - hemorrhage;
17-D - 17-DMAG.
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